Skip to main content
CLYM logo

CLYM · Climb Bio, Inc. · Webcasts, Transcripts & Audio

Track CLYM — free
$8.87 -0.46 (-4.93%) At close · Nov 5
Market Cap
$521.01M
Shares
58.74M
Volume · Nov 5 1.44M Avg daily vol (3M) 1.41M

Climb Bio, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Climb Bio, Inc. (CLYM), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Conference
Investor event
2026-11-09
Climb Bio, Inc. (CLYM) November 9, 2026 Conference
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-09-16
Climb Bio, Inc. (CLYM) September 16, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-09-09
Climb Bio, Inc. (CLYM) September 9, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-09-03
Climb Bio, Inc. (CLYM) Q2 2026 Earnings Call
Diluted EPS
$-0.18
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-04
Climb Bio, Inc. (CLYM) June 4, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-04
Climb Bio, Inc. (CLYM) June 4, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-05-19
Climb Bio, Inc. (CLYM) May 19, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-07
Climb Bio, Inc. (CLYM) Q1 2026 Earnings Call
Diluted EPS
$-0.20
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q3
2025-11-18
Climb Bio, Inc. (CLYM) Q3 2025 Earnings Call
Diluted EPS
$-0.19
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-12
Climb Bio, Inc. (CLYM) Q2 2025 Earnings Call
Diluted EPS
$-0.13
Audio Transcript Slides 8-K10-Q
Showing 1–10 of 10 webcasts
Key facts CIK 1768446 CUSIP 28658R106 13F (30d) 30 filings 26 filers Visit website Investor relations